PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Infectious Disease, Columbia University College of Physicians & Surgeons, New York, NY.\', \'Lung Transplant Program, Division of Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University College of Physicians & Surgeons, New York, NY.\', \'Department of Medicine, Division of Cardiology, Columbia University College of Physicians & Surgeons, New York, NY.\', \'Department of Medicine, Division of Nephrology, Columbia University College of Physicians & Surgeons, New York, NY.\', \'The Columbia University Renal Epidemiology (CURE) Group, New York, NY.\', \'Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.\', \'Department of Medicine, Division of Digestive & Liver Diseases, Columbia University College of Physicians & Surgeons, New York, NY.\', \'Department of Surgery, Columbia University College of Physicians & Surgeons, New York, NY.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/ajt.16314
?:doi
?:hasPublicationType
?:journal
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
is ?:pmid of
?:pmid
?:pmid
  • 32946668
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all